I. Wistuba

2.5k total citations · 1 hit paper
6 papers, 2.0k citations indexed

About

I. Wistuba is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, I. Wistuba has authored 6 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in I. Wistuba's work include Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (2 papers) and Oral and Maxillofacial Pathology (1 paper). I. Wistuba is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (2 papers) and Oral and Maxillofacial Pathology (1 paper). I. Wistuba collaborates with scholars based in United States, Japan and Australia. I. Wistuba's co-authors include Masatoshi Nomura, Kwun M. Fong, Ziding Feng, Hisayuki Shigematsu, Tsuyoshi Takahashi, J D Minna, Joachim Herz, Lin Li, Nobutaka Shimizu and Jack A. Roth and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

I. Wistuba

6 papers receiving 1.9k citations

Hit Papers

Clinical and Biological Features Associated With Epiderma... 2005 2026 2012 2019 2005 500 1000 1.5k

Peers

I. Wistuba
Georgiana Kuhlmann United States
Allan R. Li United States
Liza C. Villaruz United States
I. Wistuba
Citations per year, relative to I. Wistuba I. Wistuba (= 1×) peers Felice Mucilli

Countries citing papers authored by I. Wistuba

Since Specialization
Citations

This map shows the geographic impact of I. Wistuba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Wistuba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Wistuba more than expected).

Fields of papers citing papers by I. Wistuba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Wistuba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Wistuba. The network helps show where I. Wistuba may publish in the future.

Co-authorship network of co-authors of I. Wistuba

This figure shows the co-authorship network connecting the top 25 collaborators of I. Wistuba. A scholar is included among the top collaborators of I. Wistuba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Wistuba. I. Wistuba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Moran, César A., Annikka Weissferdt, Neda Kalhor, et al.. (2012). Thymomas I. American Journal of Clinical Pathology. 137(3). 444–450. 48 indexed citations
2.
Komaki, Ritsuko, George R. Blumenschein, I. Wistuba, et al.. (2011). The Phase II Trial Of Erlotinib And Radiotherapy Following Chemoradiotherapy For Patients With Stage III Non-small Cell Lung Cancer Has Shown A Favorable Response Profile. International Journal of Radiation Oncology*Biology*Physics. 81(2). S591–S592. 1 indexed citations
3.
Suraokar, Milind, Hung‐Yun Lin, Norma Llansa, et al.. (2008). High expression of epithelial-mesenchymal transition (EMT) markers in malignant mesothelioma and possible therapeutic intervention using an N-cadherin antagonist. Journal of Clinical Oncology. 26(15_suppl). 8067–8067. 1 indexed citations
4.
Tanaka, Fumihiro, E. Ogawa, Hiromi Wada, et al.. (2006). Clinical significance of HuR expression, an mRNA-binding protein in non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 24(18_suppl). 10098–10098. 1 indexed citations
5.
Shigematsu, Hisayuki, Lin Li, Tsuyoshi Takahashi, et al.. (2005). Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers. JNCI Journal of the National Cancer Institute. 97(5). 339–346. 1933 indexed citations breakdown →
6.
Miquel, Juan Francisco, et al.. (2000). Expression and regulation of scavenger receptor class B type I (SR-BI) in human and murine gallbladder epithelial cells. Gastroenterology. 118(4). A926–A926. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026